The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics' oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness.
UK authorizes Merck and Ridgeback Biotherapeutics' antiviral pill to treat Covid-19
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться